AI in Oncology Market Revenue Trends and Growth Potential 2026 to 2035

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global AI in Oncology Market- (Type of Cancer (Solid malignancies, Breast cancer, Lung cancer, Prostate cancer, Colorectal cancer, Brain tumor, Others), By End User (Hospitals, Pharmaceutical companies, Research Institutes, Others)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2035."

Global AI in Oncology Market Size is valued at USD 1.91 Bn in 2025 and is predicted to reach USD 7.31 Bn by the year 2035 at an 14.5% CAGR during the forecast period for 2026 to 2035.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2529

Artificial intelligence (AI) is reshaping the oncology sector by advancing cancer diagnostics, treatment planning, and patient management through sophisticated machine learning algorithms and data analytics. By analyzing large and complex medical datasets, AI systems can detect subtle patterns and provide personalized therapeutic recommendations, supporting evidence-based clinical decision-making and enhancing patient outcomes. Key technologies-including deep learning, natural language processing (NLP), computer vision, and genomics-driven analytics-are instrumental in improving diagnostic accuracy, optimizing treatment strategies, and increasing overall healthcare efficiency.

The strategic value of AI in oncology lies in its capacity to deliver precise, data-driven insights, enabling accurate diagnoses and individualized care aligned with each patient's clinical profile. AI platforms also facilitate early disease detection by evaluating patient data to identify potential risks, supporting proactive and preventive interventions. Additionally, AI-driven automation improves operational efficiency, reduces healthcare costs, and streamlines clinical workflows, positioning artificial intelligence as a transformative force in oncology and the wider healthcare ecosystem.

List of Prominent Players in the AI in Oncology Market:
• Berg
• CancerCenter.AI
• Concert AI
• GE Healthcare
• IBM Watson Health
• iCAD
• JLK Inspection
• Median Technologies
• Path AI
• Roche Diagnostics

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02

Market Dynamics: AI in Oncology
Market Drivers:
The rising global incidence of cancer-including common types such as lung, breast, prostate, colorectal, and brain cancers-is a primary driver of AI adoption in oncology. According to the American Cancer Society's 2024 report, the United States is projected to record approximately 234,580 new lung cancer cases and 125,070 associated deaths, highlighting the urgent demand for advanced oncological solutions.

Worldwide, the World Health Organization (WHO) estimates nearly 20 million new cancer diagnoses annually, emphasizing the need for enhanced diagnostic and therapeutic approaches. AI-enabled precision medicine, which integrates complex genomic datasets, advanced medical imaging, and sophisticated analytics, plays a critical role in facilitating early cancer detection, optimizing personalized treatment plans, and improving overall patient outcomes.

Market Challenges:
Despite its transformative potential, broad implementation of AI in oncology faces several obstacles. Limited access to high-quality, multi-institutional datasets and inconsistencies in electronic health record (EHR) documentation impede interoperability. The absence of standardized imaging protocols and unified data-sharing frameworks further constrains clinical application, potentially impacting diagnostic accuracy and treatment efficacy. Labor-intensive processes, such as tumor segmentation and annotation, also limit scalability. Additionally, successful deployment requires effective collaboration among oncologists, radiologists, and data scientists, introducing operational complexities within multidisciplinary healthcare environments.

Regional Trends:
North America currently leads the AI oncology market, supported by a robust healthcare infrastructure, advanced medical imaging capabilities, and a strong research ecosystem. In 2024, the U.S. is expected to report approximately 2,001,140 new cancer cases and 611,720 cancer-related deaths, reinforcing the critical need for innovative oncology solutions. The region benefits from substantial R&D investments by leading academic and biotechnology institutions, driving the development of AI-powered oncology applications.

Furthermore, a favorable regulatory environment, including supportive reimbursement policies, facilitates rapid adoption of AI solutions in clinical practice. Strong demand for accurate and efficient diagnostic and therapeutic tools continues to reinforce North America's leadership in AI-driven oncology innovation.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2529

Recent Developments:
• In May 2024, ConcertAI launched CARA AI, its advanced predictive and generative AI suite, at the 2024 ASCO Annual Meeting, offering multi-modal data management and fostering collaborative research efforts across translational to clinical development stages. Additionally, ConcertAI introduced an update to its SmartLinQ oncology quality management platform, TriaLinQ.
• In May 2024, GE Healthcare introduces Revolution RT, its new AI-enhanced oncology solution, marking a "new era" in radiation therapy computed tomography (CT). Revolution RT features innovative hardware and software to enhance imaging accuracy and streamline simulation workflows, aiming to personalize and simplify the oncology care pathway for clinicians and patients. The technology debuted at the European Society for Therapeutic Radiology and Oncology 2024 Congress in Glasgow, Scotland.

Segmentation of AI in Oncology Market-
By Type of Cancer
• Solid malignancies
• Breast cancer
• Lung cancer
• Prostate cancer
• Colorectal cancer
• Brain tumor
• Others
By End User
• Hospitals
• Pharmaceutical companies
• Research Institutes
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/ai-in-oncology-market-/2529

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.